FINWIRES · TerminalLIVE
FINWIRES

Hong Kong Stocks Retreat Amid Outflows; Beijing Shougang LanzaTech Soars in Debut

By

Hong Kong stocks retreated Wednesday as outflows from the city to mainland exchanges weighed on investor sentiment.

The Hang Seng Index fell by around 405.11 points, or 1.6%, to end at 25,633.21, while the Hang Seng China Enterprises Index decreased by 166.38 points, or 1.9%, to close at 8,596.59.

Goldman Sachs Group on Wednesday downgraded its rating on H shares to market-weight, citing the Hong Kong market's four-month underperformance against onshore peers, Bloomberg News reported.

The downgrade came amid a broad sell-off from mainland investors who appeared to be investing in semiconductors and other AI-linked shares in China.

Mainland-listed ETFs that invest in Hong Kong equities pulled 25 billion yuan from the city's market last week, the largest weekly outflow on record and a reversal from last year's steady inflows, according to Bloomberg data.

Meanwhile, the U.S. proposed additional taxes on imports from 60 economies, including China and Hong Kong, over forced-labor trade practices, the Office of the U.S. Trade Representative said.

The USTR has proposed a 10% additional tariff for economies that have partially enforced bans on the importation of certain forced labor goods, and a 12.5% tariff for all others, according to the release from the office.

In corporate news, Chinese carbon capture firm Beijing Shougang LanzaTech Technology (HKG:2553) soared in its Hong Kong debut. The firm's shares closed at HK$21.06, 44% above the offer price of HK$14.60.

Related Articles

Asia

Zydus Lifesciences Receives USFDA Warning Letter for Baddi Facility

Zydus Lifesciences (NSE:ZYDUSLIFE, BOM:532321) said it received a warning letter from the U.S. Food and Drug Administration related to its formulations manufacturing facility in Baddi, Himachal Pradesh, according to a Wednesday filing on Indian bourses.The warning letter was issued in response to a records request under the Federal Food, Drug, and Cosmetic Act, the company said. It relates to observations regarding the use of purified talc that did not meet current U.S. Pharmacopeia requirements.Zydus said the letter is not linked to an on-site inspection and does not affect current operations or supplies from the facility.

$BOM:532321$NSE:ZYDUSLIFE
Asia

GCH Technology Unit to Invest 1.3 Billion Yuan in Dongguan Electronic Materials Complex

GCH Technology's (SHA:688625) subsidiary, Guangdong Chenghe Electronic Materials, will invest up to 1.3 billion yuan to construct a high-frequency, high-speed electronic materials and high-end additives project.The subsidiary will construct the facility in Dongguan, Guangdong, China, according to a Wednesday filing with the Shanghai bourse.The complex will have a total land area of ​​140,980 square meters and will be constructed within 18 months.

$SHA:688625
Asia

Meitec to Record 14.6 Billion Yen in Dividend Income From Subsidaries

Meitec (TYO:9744) will receive dividends totalling 14.6 billion yen from four consolidated subsidiaries, effective June 4, according to a Tokyo bourse filing on Wednesday.The dividends were resolved on June 3, with Meitec Corp. contributing the largest share at 11.4 billion yen.As a result, the company will record the full dividend amount as operating income in its non-consolidated financial results for the current fiscal year.However, since these are intra-group dividends, there will be no impact on the consolidated financial results.

$TYO:9744